2019
DOI: 10.1016/j.copbio.2018.12.004
|View full text |Cite
|
Sign up to set email alerts
|

Directed evolution of carbon–hydrogen bond activating enzymes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
14
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 21 publications
(14 citation statements)
references
References 79 publications
0
14
0
Order By: Relevance
“…A specific P450 isoform is referred to by the prefix 'CYP' (CYtochrome P450) followed by a numerical designation based on homology (Nelson, 2004). P450s have a reputation for being challenging enzymes to express in heterologous systems because they are membrane bound and require dedicated reducing systems, such as the ER membrane-localized NADPH-dependent cytochrome P450 reductases (CPR) (Frey et al, 2019;Jung et al, 2011). Both of these difficulties may be partly overcome by targeting P450s to chloroplasts or cyanobacteria.…”
Section: Introductionmentioning
confidence: 99%
“…A specific P450 isoform is referred to by the prefix 'CYP' (CYtochrome P450) followed by a numerical designation based on homology (Nelson, 2004). P450s have a reputation for being challenging enzymes to express in heterologous systems because they are membrane bound and require dedicated reducing systems, such as the ER membrane-localized NADPH-dependent cytochrome P450 reductases (CPR) (Frey et al, 2019;Jung et al, 2011). Both of these difficulties may be partly overcome by targeting P450s to chloroplasts or cyanobacteria.…”
Section: Introductionmentioning
confidence: 99%
“…Already today, 2-oxoglutarate-dependent oxygenases are employed for a variety of industrially and academically relevant transformations, ranging from the production of amino acid derivatives to the chemo-enzymatic total synthesis of complex natural products (vide supra). As attested by recent enzyme engineering studies on 2-oxoglutarate-dependent oxygenases [25,99,140], the progress made in the field of protein design and evolution over the last few decades [147,148] facilitates the development of robust and active C-H functionalization biocatalysts [149]. As the integration of automation and the use of advanced computer algorithms continue to facilitate enzyme engineering, the industrial implementation of 2OGX-driven processes will be further accelerated.…”
Section: Discussionmentioning
confidence: 99%
“…Many of the biocatalysts described here and in previous works 255,256 look ready to be incorporated into screening kits for use in drug discovery laboratories. The challenges to be overcome before they are more widely used in industry have been identified for each enzyme class, and these are being tackled by numerous research groups.…”
Section: Late-stage C–h Functionalization Of Drug Leads Using Engineered Enzymesmentioning
confidence: 92%